Archives of Disease in Childhood Fetal & Neonatal · 1999 · 73 citations · 21 references
MedicineClinical SciencesPediatricsInfant HealthNeonatal HealthNeonatologyNeonatal OutcomesNeonatal Respiratory DisordersRespiratory DiseaseRespiratory Distress In NewbornsRespiratory Distress SyndromeExogenous Surfactant AdministrationGestational Age MeasurementLong-term MorbidityNeonatal Apgar ScoresNeonatal Chronic Lung DiseasePulmonary Surfactant AdministrationPulmonary Surfactant TherapySupplemental Oxygen Therapy
AIM: To determine if pulmonary haemorrhage after surfactant treatment increases short and long term morbidity and mortality in neonates weighing <1500 g at birth. METHODS: Neonates weighing <1500 g at birth who developed pulmonary haemorrhage after surfactant treatment were identified from a database. Based on the change in FIO2, pulmonary haemorrhage was classified as mild, moderate, or severe. Controls were matched for birthweight, gestational age, Apgar scores and hospital. Chronic lung disease (CLD) was defined as the need for supplemental oxygen at 36 weeks of corrected gestational age. RESULTS: From January 1990 to May 1994, 94 of 787 (11.9%) neonates treated with surfactant developed pulmonary haemorrhage. Ten were excluded because of incomplete data or lack of controls. Eighty four were included for further analysis; two acceptable matches were found in 75, while only one match was possible in nine. For the pulmonary haemorrhage group, the mean (SD) birthweight was 917 (238) g, gestational age 27 (1.9) weeks. Pulmonary haemorrhage was severe in 39 (46%), moderate in 22 (26%), and mild in 23 (27%). Moderate and severe pulmonary haemorrhage were associated with chronic lung disease or death, OR 4.4 (confidence interval 1.3-15.7) and OR 7.8 (CI 2.6-28), respectively, while mild pulmonary haemorrhage was not, OR 1.8 (CI 0.55-5.8). pulmonary haemorrhage was associated with major intraventricular haemorrhage (IVH), OR 3.1 (CI 1.5-6.4), but not with minor IVH, OR 1.3 (CI 0.6-2. 6). In the survivors who could be assessed at >/=2 years, the differences in neurodevelopmental outcome among the two groups were not significant. CONCLUSIONS: In neonates treated with surfactant moderate and severe pulmonary haemorrhage is associated with an increased risk of death and short term morbidity. Pulmonary haemorrhage does not seem to be associated with increased long term morbidity.
21
An international classification of retinopathy of prematurity
International Ophthalmology · 1985 · 1K citations
Medicine, Ophthalmology, Pediatrics +16
Bronchopulmonary dysplasia: Clinical presentation
Eduardo Bancalari, George E. Abdenour, Rosalyn Feller et al. · The Journal of Pediatrics · 1979 · 507 citations